Skip to main content
. 2016 Sep-Oct;42(5):925–931. doi: 10.1590/S1677-5538.IBJU.2015.0167

Table 2. Comparative analysis of patients with and without rebiopsy regarding measured variables.

2nd Biopsy
No Yes
Number (%) Number (%) P
Total Testosterone ng/dL
<231 ng/dL 28(10) 1(2.5) 0.217**
231–346 ng/dL 39(13.9) 8(20)
>346 ng/dL 213(76.1) 31(77.5)
Mean(SD) Mean(SD) P
Prostate Volume mL 49.7(22.5) 47.4(18.1) 0.534*
Total Testosterone ng/dL 410.9(145.2) 423.6(120.3) 0.597*
SHBG nmol/L 49.9(20.8) 50.4(18.4) 0.873*
Free Testosterone ng/dL 6.6(2.7) 6.9(3.5) 0.569*
Bioavaillable Testosterone ng/dL 161.6(65.2) 164.4(81.2) 0.807*
Albumin g/dL 4.5(0.3) 4.5(0.2) 0.640*
*

Student's t-test

**

Chi-square test

SD = Standard Deviation